生物产业是知识密集、技术含量高、多学科综合度高且渗透性强的战略性新兴产业，涵盖生物医药、生物农业、生物能源、生物制造、生物环保等多个细分领域。随着科学技术的不断进步，生物产业在治疗疾病、食品安全、可持续发展等方面发挥关键作用。研究发现，美国企业科技创新水平领跑全球，欧洲和日本优势企业竞争实力强劲；生物企业普遍重视基础科学研究与知识创新，美欧企业优势明显；全球生物企业技术创新能力差距较大，技术壁垒短期内难以突破；美国企业创新协作能力持续提升，欧洲企业发展态势良好。未来的优化路径包括提升全球首创性技术创新能力，整合多元化创新要素；基础研究与产业应用“双轮驱动”，人才引进与协同培养“双管齐下”；打造生物产业龙头企业与民族品牌，关注技术创新获利与生命科学前沿；加强生物产业集聚协同，打造产、学、研联动平台。
In the bioindustry，United States companies lead in scientific and technological innovation，while European and Japanese companies demonstrate strong competitiveness. These enterprises prioritize basic scientific research and knowledge innovation，with US and European companies having distinct advantages. There is a significant gap in technological innovation capabilities among enterprises，making it challenging to overcome technological barriers in the short term. US bioindustry companies continue to lead in technology innovation cooperation，while European companies are also making progress. To optimize for the future，it is recommended to enhance the innovation ability of the First-in-Class and integrate diverse innovation elements with Chinese characteristics. Attention should be given to basic research and industrial application，as well as to strengthening collaborative training in the introduction of biological science talents. Building leading enterprises and national brands in the bioindustry is important，along with emphasizing technological innovation profits and the forefront of life sciences. It’s also crucial to strengthen the agglomeration and coordination of the bioindustry and build a platform for industry-university-research linkage.
